ArticleNature communications2021

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation.

Enrique J Arenas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.